This Solicitation opportunity from Hawaii was posted on September 4, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

RFI J26171-To Provide Residential Substance Abuse Treatment Services for the Adult Client Services Branch, First Circuit, The Judiciary, State of Hawaii

Closed

RFI J26171State & Local

Submission Closed09/09/2025, 12:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210

New

DIBBS

SUNSCREEN PREPARATION

Solicitation # SPE2DP-27-T-0183

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

REHYDRATION SALTS FOR

Solicitation # SPE2DP-27-T-0184

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Emergency Fuel and DEF Supply ServicesThis subcontract for Emergency Fuel and DEF Supply Services involves the supply and delivery of diesel fuel and Diesel Exhaust Fluid for prime contractors working on USACE Pittsburgh District projects. The scope of work includes performing the initial fueling of generators during installation and providing ongoing replenishment at remote sites via fuel tankers to ensure continuous generator operation. The project is managed under the Department of Defense for the W072 Endist Pittsburgh agency, with performance taking place in Pittsburgh. The selected provider must strictly adhere to the Environmental Protection Plan and all applicable federal and state fuel handling regulations. Responses for this opportunity are due by December 1, 2026.

W072 Endist Pittsburgh

POSTED

DEADLINE

Medical Supply Distribution and LogisticsThis subcontract, titled Medical Supply Distribution and Logistics, involves the procurement, warehousing, and delivery of Miconazole Nitrate Powder to support prime contractors fulfilling Department of Defense supply contracts. The selected provider is responsible for the end-to-end logistics chain, including sourcing from manufacturers and managing inventory within climate-controlled pharmaceutical storage to ensure product integrity before shipping to designated DLA locations. To ensure regulatory compliance, the contractor must adhere to the Drug Supply Chain Security Act and maintain an active SAM registration. This effort falls under NAICS code 424210 and is managed by the Medical Supply Chain Pharm FSA. Interested parties must respond by November 2, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Bupivacaine Hydrochloride Injection SupplierThis subcontract involves the supply of Bupivacaine Hydrochloride Injection for prime contractors supporting Department of Defense pharmaceutical supply contracts. The supplier is responsible for providing NSN 6505-00-1387347 TYPE I (CODE M) items, ensuring that all vials are delivered in accordance with ASTM D3951 or TQ requirement IP025 for hazardous materials. Strict quality and storage standards are required, including the maintenance of USP controlled room temperature storage between 20 to 25 degrees Celsius and a guaranteed non-extendable shelf life of 24 months. The contract is managed under NAICS code 424210 for the Medical Supply Chain Pharm FSA, with the place of performance located at Fort Campbell.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM CHLORIDE INJECT

Solicitation # SPE2DP-27-T-0178

Solicitation SPE2DP-27-T-0178 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Sodium Chloride Injection, USP. The requirement is for 5 packages of 0.9% 1000ML IV plastic bags, which must be latex-free and stored at controlled room temperature between 20°C and 25°C. The items must be delivered FOB destination within 20 days of award, with inspection and acceptance also occurring at the destination. The product is subject to a non-extendable shelf life of 30 months and must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The procurement is not a small business set-aside, though it utilizes the HUBZone price evaluation preference. Technical compliance is governed by the DLA Master List of Technical and Quality Requirements, and packaging must adhere to MIL-STD-2073-1E and special instructions MPWM00001. Offerors must be registered in the System for Award Management and comply with the Buy American Act and Berry Amendment. Invoicing and payment are to be processed electronically via the Wide Area WorkFlow system. Quotations are due by November 2, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

REHYDRATION SALTS FOR

Solicitation # SPE2DP-27-T-0175

Solicitation SPE2DP-27-T-0175, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of berry flavored electrolyte oral rehydration powder (NSN 6505016462701). The requirement consists of multiple line items, including 10 packages for CLIN 0001 and 17 packages for CLIN 0003, with each package containing 100 packets. Each 21 gram packet provides a specific electrolyte solution containing 665 mg of sodium, 390 mg of potassium, 80 mg of citrate, 83 mg of magnesium, and 3 mg of zinc. The product has a total shelf life of 36 months, and it must have a minimum of 31 months remaining upon receipt by the government. Delivery is required within five days of order, with shipments directed to various locations including Guam, Germany, and the USNS John Lenthall. The contract specifies FOB Destination for delivery, inspection, and acceptance. Packaging must adhere to commercial standards such as ASTM D3951 or TQ requirement IP025 for hazardous materials, while marking must comply with Medical Marking Standard No. 1 and MIL-STD-129. This is not a small business set-aside, though HUBZone price evaluation preferences may apply. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MICONAZOLE NITRATE POW

Solicitation # SPE2DP-27-T-0157

Solicitation SPE2DP-27-T-0157 is a fixed-price contract issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Miconazole Nitrate antifungal foot powder. The requirement is for 10 cases, with each case containing 12 units of 3-ounce powder. The product is regulated by the FDA and must be stored at controlled room temperature in a cool, dry place. The original required delivery date is October 27, 2026, with a delivery timeframe of 5 days after order. Delivery, inspection, and acceptance are all set for destination at Rose Barracks South Camp in Vilseck, Germany. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must follow MIL-STD-2073-1E at Packing Level B, utilizing sealed unit containers and suitable commercial exterior shipping containers. Because the material is considered hazardous, suppliers must provide Safety Data Sheets and labels compliant with 29 CFR 1910.1200. Key regulatory requirements include the Buy American and Balance of Payments Program, the Berry Amendment, and the use of the Wide Area WorkFlow system for invoicing. Additionally, the item is subject to a non-extendable shelf life of 24 months.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Hygiene Products SupplierThis subcontract opportunity is for a supplier to provide and deliver hygiene products to prime contractors supporting State of Alabama procurement projects, specifically for the Department of Corrections in Mobile. The selected vendor will be responsible for sourcing and shipping specified products to designated state locations, ensuring all deliveries pass state inspections for quality and compliance. To be eligible, applicants must provide manufacturer reseller authorization, maintain Alabama state tax registration, and be enrolled in E-Verify. This opportunity falls under NAICS code 424210 and requires responses to be submitted by October 28, 2026.

Department Of Corrections, Mobile Wr

POSTED

DEADLINE

WHPL_ITQ-KW23102026_(DIPHENOXYLATE 2.5MG, ATROPINE 25MCG TAB)

Solicitation # Doc2449374471

Woodlands Hospital, through contracting agent ALPS Pte. Ltd, has issued an Invitation to Quote for the supply of Diphenoxylate 2.5mg and Atropine 25mcg tablets. The solicitation was posted on 23 October 2026, with a strict submission deadline of 03 November 2026 at 2300 hours Singapore Time. Interested suppliers must submit their proposals exclusively through the Ariba e-Procurement System, as hard copy submissions or responses sent via other channels may lead to disqualification. Suppliers are encouraged to use a generic company email address for registration to ensure all notifications are received. All requests for clarification must be submitted via email by 29 October 2026, with responses expected by 02 November 2026. To maintain a fair competition, the hospital will share all questions and answers with all participating bidders. Technical assistance for the submission process is available through the Ariba Helpdesk and the ALPS website training guide.

POSTED

DEADLINE

WHPL_ITQ-KW23102026_(ANIFROLUMAB 300MG per 2ML INJ (F))

Solicitation # Doc2449337317

Woodlands Hospital, through contracting agent ALPS Pte. Ltd, has issued an Invitation to Quote for the supply of Anifrolumab 300mg per 2ml injections. The solicitation was posted on 23 October 2026, with a final submission deadline of 03 November 2026 at 2300 hours Singapore Time. Interested suppliers must submit their proposals electronically via the Ariba e-Procurement System, as hard copy submissions or responses sent through alternative channels may lead to disqualification. Suppliers are encouraged to use a generic company email address for registration to ensure all notifications are received. All requests for clarification must be submitted via email by 29 October 2026, with responses expected by 02 November 2026. To maintain a fair competition, Woodlands Hospital will share all questions and answers with all participating bidders.

POSTED

DEADLINE

KTPH-TY-20261022- BEMPEDOIC ACID 180MG TABLET

Solicitation # Doc2448328922

ALPS Pte. Ltd. is seeking sources for the procurement of Bempedoic Acid 180mg tablets to be provided on a named patient basis. This sources-sought solicitation, identified by number Doc2448328922, was posted on October 22, 2026, with a response deadline set for October 29, 2026. The contract will be performed in Singapore. Interested parties may coordinate with the primary point of contact, Tiffany Yo, via email at [email hidden] or access further details through the provided Ariba portal link.

ALPS Pte. Ltd.

POSTED

6 days ago

DEADLINE

in 1 day

AI Contract Overview

The Hawaii Judiciary is seeking information and recommendations from providers to establish a contract for Residential Substance Abuse Treatment Services aimed at adult female offenders. The services are intended to deliver a comprehensive, evidence-based, offender-oriented continuum of care that addresses substance abuse issues among women ordered by the court to seek treatment. The program's primary objectives are to facilitate long-term abstinence and reduce recidivism by equipping participants with effective strategies, skills, and knowledge. The treatment modalities included in the continuum encompass assessments, education, motivational enhancement, outpatient and intensive outpatient programs, day and residential treatments, as well as therapeutic living arrangements. The solicitation, identified as RFI J26171, was posted on September 4, 2025, with a response deadline of September 9, 2025. The contract size is estimated to range between $500,000 and $2,000,000. The Hawaii Judiciary is the contracting agency, and interested providers can contact Mr. Caelan O’Meara via email or phone for further information. The initiative aims to enhance the state's capacity to deliver effective substance abuse treatment services tailored specifically for adult women within the criminal justice system, promoting rehabilitation and reducing future criminal behavior.

General Info

Agency

Hawaii Judiciary

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

HI, USA

Set-Aside

NONE

Documents

RFI J26171 - Residential Substance Abuse Treatment Services

rfi

High

RFI J26171: Residential Substance Abuse Treatment Services

rfi

High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed

PostedSep 4

Solicitation

Response DeadlineSep 9

Deadline has passed

Submission Closed

09/09/2025, 12:00:00 AM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyHawaii Judiciary

Contacts1 person available

OfficeN/A

Organization / AgencyHawaii Judiciary

Office AddressN/A

Contacts

Mr. Caelan O’Meara

contact@example.gov

+1 (555) 000-0000

Full Description

The Judiciary, State of Hawaii issues this Request for Information (RFI) pursuant to Chapter 103F, Hawaii Revised Status, to seek information and recommendations from interested providers for the planned purchase of Health and Human Services for The Judiciary to provide Residential Substance Abuse Treatment Services for the Adult Client Services Branch, First Circuit, The Judiciary, State of Hawaii. The goals of the requested service are: (1) To provide a comprehensive evidence- based, offender-oriented, continuum of substance abuse treatment services to adult women with alcohol/and other drug problems, who are ordered or directed by the court to obtain treatment; and, (2) the goal of treatment will be to assist adult female offenders, abusing or addicted to alcohol and/or other drugs with the acquisition and demonstration of effective strategies, skills and knowledge which will result in long- term abstinence and a reduction of their re-offending behaviors. The continuum includes Substance Abuse Assessment; Substance Abuse Education; Pre- Treatment/Motivational Enhancement Services; Outpatient; Intensive Outpatient; Day and Residential Treatment; and Therapeutic Living Program treatment modalities.